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EFFECTS OF DARK MALTS, DRY HOPPING, AND FILTRATION ON 
XANTHOHUMOL CONTENT AND BIOACTIVITY OF AMERICAN INDIA PALE 
ALES  
Xanthohumol (XN), a prenylated chalcone found in hops (Humulus lupulus L.) 
has been shown to possess a wide spectrum of beneficial properties including anti-
oxidant, anti-proliferative, pro-apoptotic, anti-inflammatory, anti-bacterial, anti-viral, and 
anti-malarial activities. Efforts have been made to increase the amount of XN in beers by 
modifying certain brewing ingredients and procedures. However, the effects of 
modifications such as addition of dark malts, dry hopping, and DE filtration on XN 
content and the biological activity of American India Pale Ales (IPAs) are not known. In 
this study, different brands of IPAs with and without addition of dark/roasted malts, dry 
hopping, and filtration and one non IPA as a standard were analyzed for XN, 
isoxanthohumol, total phenolic content, and antioxidant capacity. Isolated beer 
compounds and selected whole beer matrixes were used to determine the synergistic 
effect of beer compounds on proliferation and apoptosis of HCT 116 p53 +/+ colon 
cancer cells. No XN was found in the standard, and the XN content in IPAs ranged from 
0.00 to 12.69 mg/L. A heavily dry hopped IPA made with increased amounts of dark malt  
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contained higher amounts of XN compared to other IPAs. The use of dark malts was 
protective against the removal of XN and other phenolics after diatomaceous earth (DE) 
filtration and dry hopping increased XN content in beer. Whole beer matrixes with 
greater levels of XN suppressed proliferation and elevated apoptosis in colon cancer cells 
compared with isolated XN and/or IX, indicating that the biological effect of XN can be 
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Beer contains multiple compounds beneficial to health including silicone, benzoic 
and cinnamic acid derivatives, ferulic acid, vitamin B6, betaine glycine, catechins, and 
proanthocyanidins. One compound in beer that has received much attention is the hop 
derived compound xanthohumol (XN). XN is the principal prenylated chalcone in the 
hop plant (Magalhaes et al., 2008). This compound possesses health-benefitting 
properties including antioxidant, anti-proliferative, pro-apoptotic, anti-inflammatory, 
anti-bacterial, anti-viral, and anti-malarial activities (Miranda et al., 2000; Bamforth, 
2002; Gerhauser et al., 2002; Stevens et al., 2004; Gerhauser, 2005; Monteiro et al., 
2008; Magalhaes et al., 2009; 2009; Sohrabvandi et al., 2010). Interestingly, a recent 
study showed that XN increased apoptosis and suppressed cell proliferation of human 
colon carcinoma cell lines HT 29 and HCT 116 at 10 µM concentrations (Hadjiolov et 
al., 2009). Because of the wide spectrum of beneficial properties XN possesses, XAN 
technology, which includes modifying brewing ingredients (using dark, roasted malts and 
XN-enriched hop products) and brewing procedures (wort boiling, fermentation, 
maturation/storage, and filtration/stabilization) has been developed to increase the 
amount of XN in beers (Wunderlich et al., 2005; Back, 2007). The amount of XN in 
commercial beers is low: 0.2 mg/L or less (Wunderlich et al., 2005). However, addition 
of dark malts that contain several unidentified soluble substances with a molecule size 




XN during the boiling process, and reduce its isomerization to IX, a compound that is not 
as biologically beneficial as XN (Wunderlich et al., 2005; Back, 2007). By utilizing the 
combination of dark malts and XN-enriched hop products, a beer with a XN content of 
17.2 mg/L was developed (Wunderlich et al., 2005).  
One example of a beer style that may inherently contain more XN is the India 
Pale Ale (IPA). More specifically, American IPA is a style of beer containing American 
hop varieties and often utilizes dry hopping where hops are added after the wort has been 
cooled and while the beer ferments (Guinard, 1990). Dry hopping contributes to hop 
aroma but not bitterness as alpha acids need to be isomerized during wort boiling to form 
the bitter tasting iso-alpha acids (De Keukeleire, 2000). Information on bioactive 
compounds in American India Pale Ale styled beers is limited. Although one study 
analyzed prenylflavonoids in different beer styles and reported XN content of 0.16 mg/L 
in an India Pale Ale (Stevens et al., 1999b), this amount is expected to be higher in beers 
that are dry hopped. In order to determine if American IPAs contain elevated amounts of 
XN, different brands of IPAs were analyzed for total phenolics (TP), antioxidant activity, 
and amounts of XN and IX. This research also addressed 1) the effect of processing 
techniques (dry hopping and filtration) and ingredients (dark malts) on final XN and IX 
contents 2) pro-apoptotic and anti-proliferative properties of isolated compounds XN 
and/or IX and concentrated whole beer matrixes in HCT 116 (P53+/+) human colon 








REVIEW OF LITERATURE 
 
1. Beer History, Variation, and Health 
Beer has been a beverage of choice long before the American microbrewing boom 
of the latter part of the 20th century. Beer has been produced and consumed for thousands 
of years, although the exact origin of beer is unknown. The Greek historian, Herodotus, 
cited the Egyptians as making the first true beer. Other evidence suggests that Sumerians 
were the first beer drinkers some 10,000 years BCE (Bruce, 2002). Consumption of beer 
is related to a multitude of religious and cultural ceremonies and rituals and was utilized 
as food, medicine, and tonic (Darby et al., 1977). For example, beer was used for a 
variety of medicinal functions, including mouthwash, enema, vaginal douche, and for 
treatment of wounds. Modern analytical techniques have confirmed a multitude of 
inherent beer compounds, such as xanthohumol (XN) that could quite possibly be the 
scientific explanation for beers’ medicinal use throughout history. Another reason for 
beer consumption is based on sanitation. Historically, both on and off land, drinking 
water was frequently polluted, scarce, and expensive. Thus beer and other alcoholic 
beverages were used instead of water. One example of this includes a British legislation, 
which required the masters of ships to have at least two-thirds of a gallon of beer (about 
three liters) for each passenger when making a transatlantic voyage (Heron, 2003). In the 




beer consumption is limited to those older than 16 in several European nations to 21 in 
the United States (Bamforth, 2002). 
1.1 Beer Variations 
Beer is the term used to describe a fermented alcoholic beverage in which grains 
(typically barley and/or wheat) provide body and fermentable sugars that are converted to 
alcohol by yeast. Hops impart bitterness and water assists mashing, brewing, and 
fermentation (Bruce, 2002). Other types of alcoholic beverages similar to beer include 
mead (sugars from honey), braggots (sugars from grain and honey), and melomels 
(sugars from honey and fruit) (Mosher, 2004). Variations of “beer” were brewed for 
many centuries without the use of hops. Instead, mild herbs such as rosemary, mugwort, 
and yarrow were used for flavoring (Ingels, 1987; Bruce, 2002). Other variations of beer 
were produced in different areas depending on available ingredients.  
1.2 Beer and Health 
While beer was used for medicinal purposes, today beer consumption has a 
narrower purpose. It may occasionally be an ingredient in shampoos or in a range of food 
recipes including soups, sauces, breads, and cakes (Schermerhorn, 1993). However, the 
majority of beer today is consumed as a beverage, and it is the most commonly consumed 
type of alcoholic beverage in the world (Kondo, 2004). Beer contributes calories, amino 
acids, peptides, B vitamins, phenolic compounds, and other bioactive compounds to 
consumers (Kondo, 2004). Because beer contains beneficial compounds, it is of interest 
to study its beneficial effects on human health.  
Before discussing the possible health benefits of beer, it must be noted that high 
ethanol intake is associated with carcinogenesis and other chronic diseases (Gerhauser, 
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2005). Research has shown consuming 10.14 oz. or 0.3 L of beer a day reduces annual 
mortality for all causes of death compared to no or higher alcohol consumption 
(Gerhauser, 2005). This provides evidence that beer consumption, in moderation, can be 
beneficial to the body. Other alcoholic beverages have long been known for possessing 
beneficial compounds, for example, wine contains resveratrol and other phenolic 
compounds associated with positive effects on health. Wine receives favorable publicity, 
yet beer does not (Bamforth, 2002). This may be due to the fact that drinking wine is 
associated with having a higher socio-economic status, better healthcare, and consuming 
healthier foods. People who smoke daily tend to drink more beer, more coffee, and less 
tea (Bamforth, 2002). In the past, perhaps beer was harmful to the body because of 
carcinogenic volatile nitrosamines contributed by directly fired malt. This practice has 
been halted in the malt house, and currently malt contains only trace amounts of these 
compounds (Smith, 1994).   
2. Beer Ingredients and Chemical Compounds 
Beer is made from four essential ingredients: water, malt, hops, and yeast. Water 
is 90% of the composition of most beers (Bamforth, 2006). The other major ingredient in 
beer is malt. A few hundred grams of malt is used to make one liter of beer (De 
Keukeleire, 2000). Malt, typically made from barley, enhances the body of the beer. 
Because starches in barley need to be converted into fermentable sugars, the grain is 
subjected to a controlled steep and germination, during which time enzymes are formed 
in the barley grain kernel. These enzymes break down starch and yield fermentable 
sugars (De Keukeleire, 2000). Starch-to-sugar conversion is stopped by a heating process 
called kilning (Briggs, 1998). Kilned malt can produce pale malt with significant 
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enzymatic activity. Malts also can go through another process of roasting, which 
develops other flavors and produces a darker color. Roasted malt has limited enzyme 
activity and a distinct taste such as coffee and chocolate (Briggs, 1998). Some beers are 
brewed exclusively with pale malt. Others are darker in color because they are brewed 
with dark malts. During kilning and roasting, developed colors are due to caramelization 
of sugars and Maillard-type reactions (De Keukeleire, 2000). All malt is not created equal 
and chemical composition can vary widely depending on the process (kilning or roasting) 
and procedure (time and temperature).  
2.1 Malt-Derived Compounds 
Benzoic and cinnamic acid derivatives, catechins, proanthocyanidins, and 
flavones are found in small quantities in most beers and possess radical scavenging 
activity (Gerhauser, 2005). Kimura et al. (1999) showed that a malt derived compound, 
betaine glycine, suppressed a precursor to colon cancer, aberrant crypt formation, when 
induced by azoxymethane (AOM), a potent colon specific carcinogen. Malt contributes 
other beneficial compounds to beer: e.g., silicone, ferulic acid, and vitamin B6.  These 
compounds are also noted for being present in beer and generating beneficial responses in 
the human body (Bamforth, 2002; Casey et al., 2009). Samaras et al. (2005) showed 
antioxidant activity increased with the malt’s temperature and was higher for roasted than 
kilned malts. Phenolics were the main contributors to antioxidant activity for kilned 
malts. In roasted malts, Maillard reaction products were responsible for the majority of 





2.2 Hop-Derived Compounds 
Although 70-80% of beer polyphenolics come from malt and 20-30% from hops 
(Gerhauser, 2005; Gorjanovic et al., 2010), much of the current research on bioactives 
focuses on hop-derived compounds. The female hop plant is widely grown and cultivated 
for its secondary metabolites, which are used during brewing to impart bitterness and 
aroma (Ceh et al., 2007). There are many health-related implications for this. Hops 
contain bitter acids, essential oils, and prenylflavonoids, which are produced by the 
lupulin glands in the female hop cone (Magalhaes et al., 2008). Hops are the only source 
of these compounds in beer and some may be beneficial to the humans. For example, XN, 
isoxanthohumol (IX), 8-prenylnaringenin (8PN), alpha acids, and others all possess 
multiple health benefits (Gerhauser, 2005). XN, is the principal chalcone prenylflavonoid 
in hops (0.2-1.1% w/w) (Magalhaes et al., 2008). It was first isolated from hops by Power 
et al. (1913) and was called xanthohumol after “xanthos,” Greek for yellow, and 
“humulus,” Latin for hops. XN is reported to be slightly bitter tasting (Haseleu et al., 
2010)  and is also present in Sophora flavescens Aiton (Jung et al., 2005), a Chinese 
medicinal plant.  
 
          
 I     II 
Figure 2.1 Xanthohumol (I) and Isoxanthohumol (II)  
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During the brewing process, XN is converted into its isomeric flavanone form, 
IX, which is typically the main prenylflavonoid in beer. This conversion takes place 
because XN has one hydroxyl available for ring closure, thus IX is formed as heat 
catalyzes this reaction (Stevens et al., 1999a). Two other prenylated chalcones exist in 
female hop cones: desmethylxanthohumol and 3geranylchalconaringenin. These 
compounds also isomerize. Desmethylxanthohumol undergoes spontaneous or base-
catalyzed cyclization during dry storage and forms 8PN, a bioactive compound (Stevens 
et al., 2004). While traces of prenylated flavonoids other than XN and IX are found in 
beers, the focus of this project will be on these prenylated flavonoids because of their 
inherent health benefits and potential final beer concentrations. XN and its isomeric form, 
IX have demonstrated a multitude of biological and/or pharmacological activities that are 
well summarized by Magalhaes et al. (2009). Potential benefits of XN have been well 
documented in numerous reviews (Gerhauser et al., 2002; Stevens et al., 2004; 
Gerhauser, 2005; Magalhaes et al., 2009).  
2.2.1 Antioxidant Activity 
Antioxidant activity of XN, ie. the scavenging of reactive species, was analyzed 
by Gerhauser et al. (2002).  This investigation showed XN was 8.9 and 2.9 fold more 
potent scavenger than trolox at 1 mM for hydroxyl and peroxyl radicals in the ORAC 
(oxygen radical absorbance capacity) assay. XN was a potent scavenger of superoxide 
anion radicals (Gerhauser et al., 2002). Scavenging of reactive species is one way XN can 
play a role in preventing the development of cancer and neurodegenerative diseases such 
as atherosclerosis (Magalhaes et al., 2009). At concentrations of 5 and 25 µM in vitro, 
XN inhibited low-density lipoprotein (LDL) oxidation (Miranda et al., 2000). Stevens et 
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al. (2003) showed that prenylated chalcones, such as XN, and non-prenylated flavonone 
analogues, such as IX, inhibited peroxynitrite-mediated oxidation of LDL at micromolar 
concentrations. Prenylflavonoids are more lipophilic than phenolic acids and other 
polyphenols, and “may be more effective antioxidants at lipophilic surfaces such as 
membranes and low-density lipoprotein” (Stevens et al., 2004). The findings suggest that 
hop-derived prenylchalcones and prenylflavonoids found in beer might protect human 
LDL from oxidation (Miranda et al, 2000). Vinson et al. (2003) tested the effect of lager 
and dark beer on atherosclerosis in cholesterol-fed hamsters using two different 
concentrations (high and low) of beer solutions. At high doses, both significantly 
inhibited atherosclerosis, but at the low dose only the lager showed a significant decrease 
in atherosclerosis (P < 0.01) (Vinson et al., 2003).  Both beers decreased LDL oxidation 
at high concentration. In a human study, 500 ml of beer caused an increase in plasma 
antioxidant activity using the telomere repeat amplification protocol assay (TRAP) (P < 
0.05) (Ghiselli et al., 2000). 
2.2.2 Antiproliferative/Anticarcinogenic/Antiangiogenesis and Anti-inflammatory Activity 
XN was found to be 10 to 200-fold more active than resveratrol in preventing 
carcinogen-induced preneoplastic mammary lesion formation, which is the precursor 
stage of mouse mammary tumorigenesis (Gerhauser et al., 2002). Ferk et al. (2010) 
showed XN and IX limited these preneoplastic lesions as well as DNA damage in liver 
and colon cells by beneficially affecting heterocyclic aromatic amine amino-3-methyl-
imidazo[4,5-f] quinoline (IQ). XN was found to increase apoptosis and supress cell 
proliferation of human colon carcinoma cell lines HT 29 and HCT 116 at 10 µM 
concentrations (Hadjiolov et al., 2009). These observed effects of XN on colon cancer 
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cells can be attributed to XN’s ability to increase activation of caspase 3 enzymes, inhibit 
DNA synthesis, and increase induction of cell cycle arrest in S-phase (Miranda et al., 
2000; Hadjiolov et al., 2009). 
Futhermore, XN decreases the activity of the nuclear factor kappa B (NFkB) 
pathway, inhibiting both breast cancer and host cells (Monteiro et al., 2008). Prenylated 
flavanones were also found to enhance quinone reductase (QR) activity as an indication 
for elevated detoxification of toxic and reactive chemical species (Gerhauser et al., 2002). 
In an in vivo study using rats, XN reduced tumor-induced neovascularisation by 33% in 
comparison with the untreated control group (Albini et al., 2005). Prenylated flavanones 
had anti-inflammatory potential by inhibiting inducible nitric oxide synthases (iNOS) 
induction and COX-1 activity (Gerhauser, 2005).  
2.2.3 Anti-bacterial Activity 
Although the anti-bacterial activity of hop resins has been documented and 
summarized by Magalhaes et al. (2009), XN’s role in this activity is lesser known. One 
study compared the antimicrobial activity of several hop components against strains of 
Streptococcus (S. mutans, S. salivarius, and S. sanguis) with some essential oils 
commonly used in commercially available mouthwashes (Bhattacharya et al., 2003). At 
concentrations of 50 µg per disc, XN (nmol) showed inhibitory affects against all three 
strains of bacteria. A study by Natarajan et al. showed XN, and other hop-derived 
compounds, possessed a positive co-action against certain Gram-positive and Gram-
negative bacteria when paired with antibiotics in in vitro experiments (Natarajan et al., 
2008).  
2.2.4 Anti-viral Activity 
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XN was shown to have anti-viral activity against certain DNA and RNA viruses. 
Specifically, this compound was found to have inhibitory affects against HIV-1-induced 
cytopathic effect and to inhibit HIV-1 replication in peripheral blood mononuclear cells 
(Bhattacharya et al., 2003). XN also showed anti-viral activities against cytomegalovirus 
(CMV), which demonstrates XN possesses anti-herpes virus activity at concentrations of 
1.6 mg/L (Buckwold et al., 2004). Because of these findings, XN might prove to be a 
useful compound in the fight against several virus infections.  
2.2.5 Antifungal Activity  
XN was found to be one of the most potent of all hop compounds against certain 
human pathogenic fungi (Trichophyton mentagrophytes, Trichophyton rubrum, and 
Mucor rouxianus) (Mizobuchi et al., 1984). While XN was only a weak inhibitor of 
Mucor rouxianus, at a concentration of 3.13 ug/mL, XN was found to inhibit the growth 
of both Trichophyton mentagrophyte and Trichophyton rubrum more efficiently than the 
positive control griseofulvin.  
2.2.6 Anti-malarial Activity 
Malaria (caused by parasites Plasmodium falciparum and Plasmodium vivax) is 
one of the most common infectious diseases and is responsible for more than one million 
deaths annually (Nowakowska, 2007; Magalhaes et al., 2009).While certain strains of the 
disease can be treated by anti-malarial drugs, such as chloroquine, certain drug-resistant 
strains require other forms of defense (Nowakowska, 2007; Magalhaes et al., 2009). One 
study by Herath et al. (2003) showed XN was active against D6 and W2 strains of P. 
falciparum that are chloroquine sensitive and resistant, respectively. A similar study by 
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Frolich et al. (2005) showed XN was also protective against chloroquine-sensitive strain 
poW and the multiresistant clone Dd2.  
2.2.7 Anti-obesity Activity 
Prenylated flavonones could reduce the risk of metabolic syndrome, since they 
had anti-obesity effects in high fat diet-consuming rodents (Miura et al., 2005). 
Chalcones, such as XN, were found to have a beneficial effect on farnesoid X receptor 
(FXR).  FXR is a selective bile acid receptor modulator, which lowers serum or hepatic 
triglyceride levels, regulates the genes involved in bile acid transport, and plays a role in 
the regulation of carbohydrate metabolism (Nozawa, 2005).  
2.2.8 Estrogenic Activity 
Hops have been reported to possess estrogenic properties (Stevens et al., 2004). It 
was recently shown that XN does not possess intrinsic estrogenic potential and IX is a 
weak estrogen agonist (Stevens et al., 2004). 8-Prenylnaringenin (8PN) has been 
identified as one of the most potent phytoestrogens. Rat studies confirmed 8PN is an 
estrogen agonist in female reproductive organs (Diel et al., 2004). Other estrogen binding 
studies and in vitro investigations have shown that 8PN and other prenylated flavones are 
selective estrogen receptor modulators. XN might have an influence on estrogenic 
potential because it can undergo cyclization to IX and be metabolized by liver enzymes to 
form 8PN (Nikolic, 2005).  
XN and humulone (an alpha acid) were shown to be strong inhibitors of bone 
resorption (Stevens et al., 2004). Although scientific literature is not yet supporting using 
hops for treatment of premenopausal problems, such as hot flashes and prevention of 
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osteoporosis, there is a possibility of its application for prevention of these conditions in 
the future (Bowe et al., 2006).  
2.2.9 Other Hop-Derived Constituents and Health Benefits 
Other hop-derived beer constituents include alpha acids. While female hop cones 
contain both beta and alpha acids, beta acids are extremely sensitive to oxidation and do 
not survive the brewing process. During wort boiling, alpha acids go into solution and are 
isomerized into iso-alpha acids. Iso-alpha acids represent one of the most abundant 
classes of polyphenolic compounds in beer and are present in concentrations of up to 100 
mg/L in extremely bitter English ales (Stevens et al., 2004). Humulone is the primary 
alpha acid occurring in most hops and possesses many beneficial health properties 
including: radical-scavenging, lipid peroxidation inhibitory activity, inhibition of bone 
resorption, anti-inflammatory activity, tumor suppression, and prevention of angiogenesis 
(Stevens et al., 2004).  In addition, isohumulones are the dual agonists of both PPARα 
and PPARγ and have been found to improve insulin sensitivity in high fat diet-fed mice 
with insulin resistance or in patients with type 2 diabetes (Nozawa, 2005).  
2.2.10 XN Toxicity 
 Presented evidence suggests XN possesses positive biological activity. Only a 
handful of studies have addressed XN consumption and toxicity. The most recent study 
by Dorn et al. (2010) investigated liver function and homeostasis of mice receiving a 
daily XN dose of approximately 1000 mg/kg b.w. for three weeks. Results were void of 
any signs of toxic effects on the lung, heart, thymus, spleen, kidney, liver, and colon upon 
macroscopical, histological and serum analysis (Dorn, 2010). This is in line with other 
safety studies on XN, with one exception. A study by Hussong et al. (2005) addressed the 
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toxicity and influence on fertility and offspring development on rats fed 1000 mg XN/kg 
body weight (b.w.) per day. Results revealed reduced liver weights (30–40%) in rats 
receiving this elevated dose of XN in comparison with the control group. While this 
indicates weak hepatotoxicity, no other negative biological of physiological effects were 
found (Hussong et al., 2005).  
 
Figure 2.2 Summary of XN biological properties 
2.2.11Continuing XN and Beer Research 
Exact concentrations of XN needed for health-promoting effects in humans are 
not known and require further pharmacological experiments. Studies on the 
pharmacodynamics, pharmacokinetics, and metabolites of XN indicate the compound is 
minimally recovered after intake likely resulting from low absorption, rapid excretion, 
and/or extensive metabolization (Yilmazer et al., 2001; Hanske et al., 2010). This 
metabolization of XN can be attributed to both phase I and II enzymes as well as human 
intestinal microbiota (Hanske et al., 2010). Furthermore, it is known that in very acidic 
conditions, such as in the stomach, XN can undergo cyclization to IX. Compared with IX, 
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XN forms fewer metabolites during incubation with human liver microsomes and types 
of XN metabolites produced differ depending on the species of microsomes (Nikolic et 
al., 2005). Thus, the multiple biological effects reported after XN administration must be 
taken with caution as the complex nature of XN metabolites workings within the body 
have yet to be investigated.  
The actual amount of XN found in beer ranges from between 0.02 mg/L to 10 
mg/L (Biendl et al., 2004a; Wunderlich et al., 2005) while the concentration of IX can 
range from 0.0 to 3.5 mg/L (Stevens et al., 1999b). This large range is due to usage of 
specific ingredients and manipulation of the brewing process. The rationale behind 
research on XN in beers is that currently the only way Westernized society’s consumers 
are getting any of it is through beer consumption. If XN can have beneficial properties on 
human health, effort should be directed into maximizing its amount in the final product 
and understanding underlying molecular mechanisms for biological activity.  
3. Outline of Beer Production 
3.1 Milling 
When discussing beer and bioactive compounds, it is advantageous to have an 
understanding of the beer-making process. Thus, a brief overview of the main brewing 
procedures are outlined. Beer production over the years has developed into a highly 
automated science that still incorporates some amount of art and human effort. The 
essential ingredients of beer include malt, water, hops, and yeast. The brewing process 
involves manipulation of these ingredients, thermal processing, and fermentation. The 
brewing process begins with creating a grain bill with types of malted grains. These 
grains must be milled before the mash-in process begins in order to crack the husk 
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surrounding the internal starches, sugars, and enzymes, making them readily available in 
the mashing process (Lewis et al., 2001). The husk should be cracked but kept intact as 
much as possible, as the intact husk will help with filtration of the wort.  
3.2 Mashing  
After the grain is milled, the mash in process begins, and the malted and milled 
grains are combined with water to form a thick “oatmeal-like” consistency. In addition to 
barley malt, adjuncts are often added to the mash. These adjuncts can act as substrates for 
malt enzymes (Bamforth, 2006) and increase the amount of fermentable sugars. Adjuncts 
also impart unique flavor and color to the final beer. During mashing, grain enzymes 
continue to break down the starch and complex sugar matrix of the hydrated malted 
grains. Mashing temperatures and equipment can vary depending on the method used: 
infusion, decoction, double or temperature programmed mashing (Lewis et al., 2001). 
Once sufficient time has passed and conversion of grain starches to fermentable sugars 
has leveled off, the sweet liquid, called wort, is slowly drawn off the bottom of the grain 
bed and re-circulated back to the top of the grain bed to clarify the wort. The grain bed, 
especially the hulls, acts as a filter bed, so that only the wort is removed and continues on 
to the next process. Next, the lautering process begins and the sweet wort is drawn off the 
bottom and a small amount of hot water is added to the top of the grain bed in order to 
rinse out and utilize all of the sweet wort. The contents remaining in the mashing vessel, 
called brewers spent grain (BSG), can be utilized as products for animal feed, cultivation 





3.3 Boiling  
The sweet wort is transferred into a separate kettle and boiled. Boiling is done for 
several reasons. It concentrates the wort by evaporating water, evaporates volatiles in 
wort, improves wort color and flavor formation, stabilizes and sterilizes the wort, 
inactivates all residual enzymes, precipitates out unwanted protein-polyphenol 
compounds, and is beneficial for extraction of hop bittering compounds (Bamforth, 2000; 
Lewis et al., 2001). Hops are added during boiling at different times to control high 
foaming (early in the boil), to promote beer bitterness (throughout the boil), and to 
provide aroma and flavor (late in the boil) (Lewis et al., 2001). Compounds in hops, 
specifically alpha acids, are isomerized by a heat-catalyzed event. This changes the 6-
carbon ring to a 5-carbon ring (Lewis et al., 2001). Alpha acids are insoluble in beer and 
when isomerized, the iso-alpha acids are soluble and contribute desirable bitter qualities 
to beer.    
3.4 Fermentation 
After boiling, the wort is whirlpooled, which is a centrifugal action that helps 
collect hot break (undesirable flocculated proteins) and hop residues in the center of boil 
kettle (Lewis et al., 2001). The clear wort is drawn off the bottom and ideally all of the 
unwanted hot trub (a combination of hot break and hop residues) is left behind. Next the 
wort is cooled to pitching yeast temperatures, which range between 21.1-26.7°C (70-
80°F) for ale yeast strains and 7.2-12.8°C (45-55°F) for lager yeast strains (Anonymous, 
2010). Typically, yeast is pitched at a concentration of 10
7 
cells/mL (Lewis et al., 2001). 
The yeast cells grow and multiply producing ethanol, carbon dioxide, and other complex 
flavors from fermentable sugars in the wort. Fermentation can be divided into several 
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stages. The main fermentation, called primary fermentation, is when the majority of 
ethanol is produced. This is often followed by a slower process at lower temperatures 
(Bamforth, 2000). This secondary fermentation allows for yeast to scavenge any oxygen 
present, allows time for yeast sedimentation, encourages formation of chill haze particles, 
and matures the flavor of beer (Bamforth, 2000; Lewis et al., 2001). Secondary 
fermentation may also be called conditioning or maturation. After fermentation, beer can 
go through a clarification process, such as sedimentation, centrifugation, and/or filtration. 
These processes can remove particles from the beer, sometimes beneficial compounds. 
For example, polyvinylpolypyrrolidone (PVPP) has been found to remove multiple 
polyphenolic compounds (Whittle et al., 1999).  
3.5 Beer Styles 
The manipulation of the brewing process and/or brewing ingredients will produce 
a different beer and/or style. For example, adding roasted malts to a pale malt bill will 
produce a darker beer, perhaps a stout or porter-styled beer. Using a bottom fermenting 
yeast will produce a lager whereas a top fermenting yeast which will produce an ale. 
Changes to the actual procedure will produce a different beer as well. For example, 
certain beers, especially those produced in Germany, are produced under Reinheisgebolt. 
This is the German (Bavarian) Purity Law established in 1516, which mandates that only 
barley (and sometimes wheat) malt, water, hops, and yeast may be used to produce beer 
using standard German brewing practices: grains are mashed, wort is boiled, and hops are 
only added to the wort during boil (Wunderlich et al., 2005). Because of this, certain 
styles, such as the American India Pale Ale, in which hops are added to the beer during 
fermentation, are not producible. Other techniques include high-gravity brewing, which is 
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when wort possesses a higher than normal sugar concentration (15―20°P original 
gravity) (Stewart, 2010). Dilution with water (usually carbon filtered and deoxygenated) 
is required at a later stage in processing to obtain sales-gravity beer (Lewis et al., 2001). 
Using high gravity brewing can be used to meet increased production demands without 
significant expansion of brewing, fermenting, and storage facilities. Additionally, high 
gravity brewing can help increase beneficial compounds, such as XN, in the final beer 
(Stevens et al., 1999a).   
3.5.1 Low-alcohol beer 
Normal beer contains 2.5-13% ethanol (v/v) (Sohrabvandi et al., 2010). Recently, 
there has been an increased demand for non-alcoholic beers (also called low-alcohol beer 
or near beer). This is likely due to consumer sets that enjoy the taste and organoleptic 
qualities of beer, yet do not want to consume ethanol for health, religious, or safety 
reasons. In the United States, non-alcoholic beers must contain less than 0.5% alcohol by 
volume and beer falling within this parameter can be produced by utilizing many 
different techniques. These techniques can be broken up into two categories: restricted 
alcohol fermentations and alcohol removal. The first category focuses on reducing the 
amount of fermentable sugars in the fermenting liquid or altering fermentation yeast. 
Examples of this method include using high mashing temperatures to inactivate enzymes 
that break down malt starch matrixes, using a yeast strain that is unable to produce or 
produces very little amounts of ethanol, and simply not pitching yeast into wort. Once 
alcohol is produced in normal fermenting beers, certain procedures can be utilized to 
remove the inherent alcohol. Distillation, water vapor/gas stripping under vacuum, 
dialysis, reverse osmosis, and osmotic distillation are all examples of this technique 
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(Sohrabvandi et al., 2010).  The production of non-alcoholic beers can result in improper 
sensory characteristics, such as off flavors/defects and immature flavor profiles. While 
the sensory characteristics may be lacking, many non-alcoholic beers are available on the 
market, and there is certainly room for another, especially if it possesses improved flavor 
and biological beneficial profiles.  
4. Critical Steps to Increase Beneficial Compounds in Beer:  
Current brewing methods for commercial beers contain 5% or less of the XN 
content found in the hops used to make the beer (Wunderlich et al., 2005). Another 
researcher found that in trial brews the overall yield of XN was 22-30%, although the 
majority was present in the isomeric IX form (Stevens et al., 1999a). The amount of XN 
in commercial beers lies at relatively low levels: 0.2 mg/L or less (Wunderlich et al., 
2005). Specific concentrations of XN needed for health-promoting effects are not known 
and require further pharmacological experiments, but the fact remains that currently the 
only way consumers are currently getting any amounts of this compound is through beer 
consumption. Thus, research has been conducted to increase amounts of XN in beer. 
Recent efforts focused on modifying brewing ingredients and procedures within 
Reinheisgebolt, thus dry hopping is not warranted or allowed.  Wunderlich et al. (2005) 
developed a practice, called XAN technology, to increase XN content in beer. Xan 
Technology includes using enriched hop products, dark, roasted malts, and modifying 
specific brewing practices, which are explained below. An additional practice that could 
be utilized to increase XN content in final beer is dry hopping, although this hypothesis 
has yet to be proven.  
4.1 XN-Enriched Hop Products 
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Another new development being used to increase XN content in beer is XN-
enriched hop products. XN fractionates with pure resin during ethanol extraction but is 
not extracted by carbon dioxide, thus the amount of XN in various commercial hop 
products differs depending on the extraction process (Biendl et al., 2004b). For example 
Biendl et al. (2004b) found that pellets recover 95%, ethanol extract recovers 95%, and 
CO2 extract recovers less than 5% XN in the original hop cone. Hopsteiner, an 
international company specializing in hops and hop products, carries five specialized 
products containing increased quantities of XN, and these products have been used in 
multiple experiments (Biendl et al., 2004a; Wunderlich et al., 2005). Utilizing enriched 
hop products resulted in an increase in XN content in final beer. Beer with more than 10 
mg XN/L was produced (Wunderlich et al., 2005).  
4.2 Roasted Malts 
XAN technology involves using dark, roasted malts in addition to pale malts in 
the grain bill. Researchers (Walker et al., 2003; Wunderlich et al., 2005) have shown the 
use of dark, roasted malts has a positive effect on XN recovery in the final beer. 
Wunderlich et al. (2005) reported several unidentified soluble substances with a molecule 
size range of 600,000-300,000 Da (dalton: unit used for recording mass on a molecular 
scale) contained in dark malts form complexes with and protect XN during the boiling 
process and reduce its isomerization to IX. Perhaps HMW (high molecular weight) 
melanoidins, a Millard reaction compound, are the specific malt derived substances 
responsible for this increase. Coghe et al. (2006) reported HMW melanoidins (> 70,000 
Da) might likely be less soluble in wort. If melanoidins form a complex with XN and are 
less soluble in wort, XN would be protected during the boiling process.  
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No matter what the exact compound responsible for protecting XN, a replacement 
of 10% pale malt with roasted malt (and use of XN-enriched hop products) resulted in a 
beer with a XN concentration of 17.2 mg/L (Wunderlich et al., 2005).  Interestingly, the 
complex, symbiotic relationship of XN and certain roasted malt substances had a 
protective measure against certain types of filtration. Wunderlich and Back (2007) 
reported XN content in beer with roasted malts was reduced to a minimum reduction of 
50% after PVPP filtration, while almost all XN was removed in pale beers receiving 
PVPP filtration. 
4.3 Boiling, Cooling, Filtration, and Fermentation 
XAN technology requires a boiling regimen that lasts for less than one hour and 
calls for the addition of hops in the last five minutes of the boil. In addition, XAN 
technology calls for high gravity brewing and the addition of cool water to bring down 
the wort temperature to pitching temperatures. One reason behind these last four 
recommendations is to reduce the amount of heat the hops are exposed to, as heat 
catalyzes the isomerization of XN into IX (Stevens et al., 1999a). Utilizing high gravity 
brewing (production of wort with a higher concentration of sugars) increases the 
solubility of XN and other prenylfavonoids, which keeps them in solution and increases 
the content in the final beer (Stevens et al., 1999a). XAN technology also recommends 
altering other steps beyond the wort boil, including fermentation and 
filtration/stabilization. Reduced yeast pitching rates and recycling of yeast are 
recommended to improve XN recovery. However, this research shows the impact of yeast 
on XN concentrations is not clear (Wunderlich et al., 2005). XAN technology negates the 
use of krausening, the term used for adding in fresh wort to fermented beer before 
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bottling as a way to induce natural carbonation, although the justification for this is not 
explained (Wunderlich et al., 2005). Finally, XAN technology calls for minimal filtration. 
This is because many filtration methods, specifically PVPP, activated carbon, and even 
centrifugation, drastically reduces the amount of XN in the final beer (McMurrough et 
al., 1995; Wunderlich et al., 2005).   
 
Figure 2.3  Xan Technology summary (Magalhaes et al., 2009) 
4.4 Explanation of Other XN Losses 
While increasing the amount of XN in hop products might logically contribute to 
an increased amount of XN in the final beer product, this is not the case as the majority of 
XN is isomerized to IX during the boiling process. Moreover, the bolstering affects XAN 
technology can have on the final XN content in beer cannot completely counteract the 
losses throughout the brewing process. Efforts to quantify XN content in all brewing 
ingredients and throughout the entire brewing/fermentation process yielded information 
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on the causes for XN losses. Reasons include incomplete extraction from hops into wort, 
adsorption to insoluble malt proteins, adsorption to yeast cells and cold trub, and 
isomerization to IX (Stevens et al., 1999a). Interestingly in Stevens’ experiment, 27% of 
XN was missing from the total amounts measured in the final products. “Missing” 
amounts of XN were also seen in other experiments as well (Magalhaes et al., 2008).  
5. Knowledge Gaps: Current Research 
Beer recipes and styles have morphed since their inception thousands of years ago 
and often without any restrictions, such as purity laws. Thus, there exists a multitude of 
beer styles on the international market that do not adhere to German purity regulations. 
However, the current research has focused on increasing XN contents in beer produced 
under the German purity law. One example of a beer that may contain more XN than the 
average beer is the India Pale Ale (IPA) style beer. The IPA was first produced in 
Victorian England and it possesses a more pronounced hop flavor and aroma due to 
utilizing higher amounts of hops. Utilizing hops in high amounts helped protect beer from 
spoilage during transportation to India, hence its namesake. Furthermore, the American 
IPA has a prominent to intense hop aroma and many versions are dry-hopped. Dry-
hopping is a brewing term to describe when hops are added after the wort has cooled and 
while the beer ferments (Guinard, 1990). Dry hopping contributes to hop aroma but not 
the perceived bitterness as alpha acids need to be isomerized during wort boiling to form 
the bitter tasting iso-alpha acids (De Keukeleire, 2000). Thus, the result of dry hopping is 
a beer with intense hop aroma. Because the dry hops are not exposed to heat, in theory, 
their inherent XN should be preserved, although some losses from insufficient extraction 
and adsorption into cold trub are expected. Future research should focus on identifying 
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amounts of XN in American IPAs, evaluate the effect (on XN content in final beer) of 
adding dark malt to an American IPA formula, and investigate the effects of filtration on 
XN contents in IPA styled beers. Currently, little research has been done to address the 
amount of XN and IX in American IPAs or any other dry hopped beers. While one study 
analyzed prenylflavonoids in different beer styles and reported an XN content of 0.16 
mg/L in an India Pale Ale (Stevens et al., 1999b), this amount is expected to be higher in 
beers that are dry hopped.   
Objectives 
 To determine amounts of XN and IX content in samples of American IPAs.  
 To determine if adding dark malt to an American IPA formula had an effect on 
XN content in final beer. 
 To investigate the effect of DE filtration on final XN contents in American IPAs. 
 To evaluate the difference in XN content in a non dry hopped and a dry hopped 
beer formula.  
 To determine the total phenolic and antioxidant capacity of beer samples.  
 To identify the effect of isolated beer compounds and whole beer matrix on 














EFFECTS OF DARK MALTS, DRY HOPPING, AND FILTRATION ON 
XANTHOHUMOL CONTENT AND BIOACTIVITY OF AMERICAN INDIA 




Xanthohumol (XN), a prenylated chalcone found in hops (Humulus lupulus L.) 
has been shown to possess a wide spectrum of beneficial properties. Efforts have been 
made to increase the amount of XN in beers by modifying certain brewing ingredients 
and procedures. However, the effects of modifications such as addition of dark malts, dry 
hopping, and DE filtration on XN content and the biological activity of American India 
Pale Ales (IPAs) are not known. In this study, different brands of IPAs with and without 
addition of dark/roasted malts, dry hopping, and filtration and one non IPA were 
analyzed for XN, isoxanthohumol (IX), total phenolic content, and antioxidant capacity. 
Isolated beer compounds and selected whole beer matrixes were used to determine the 
synergistic effect of beer compounds on proliferation and apoptosis of HCT 116 p53 +/+ 
human colon cancer cell lines. The XN content in IPAs ranged from 0.0 to 12.69 mg/L. A 
heavily dry hopped IPA made with increased amounts of dark malt contained higher 
amounts of XN compared to other IPAs. The use of dark malts was protective against the 
removal of XN and other phenolics after diatomaceous earth (DE) filtration and dry 
hopping increased XN content in beer. Whole beer matrixes with greater levels of XN 




isolated XN and/or IX, indicating that the biological effect of XN can be bolstered in the 




Beer contains multiple compounds beneficial to health including silicone, benzoic 
and cinnamic acid derivatives, ferulic acid, vitamin B6, betaine glycine, catechins, and 
proanthocyanidins. One compound in beer that has received much attention is the hop 
derived compound xanthohumol (XN). XN is the principal prenylated chalcone in the 
hop plant (Magalhaes et al., 2008). This compound has been found to possess a number 
of health-benefitting properties including antioxidant, anti-proliferative, pro-apoptotic, 
anti-inflammatory, anti-bacterial, anti-viral, and anti-malarial activities (Miranda et al., 
2000; Bamforth, 2002; Gerhauser et al., 2002; Stevens et al., 2004; Gerhauser, 2005; 
Monteiro et al., 2008; Magalhaes et al., 2009; 2009; Sohrabvandi et al., 2010). A recent 
study showed that XN (10 µM) increased apoptosis and reduced cell proliferation of 
human colon carcinoma cell lines HT 29 and HCT 116 at 10 µM concentrations 
(Hadjiolov et al., 2009). Because of the wide spectrum of beneficial properties XN 
possesses, XAN technology, which includes modifying brewing ingredients (using dark, 
roasted malts and XN-enriched hop products) and brewing procedures (wort boiling, 
fermentation, maturation/storage, and filtration/stabilization) has been developed to 
increase the amount of XN in beers (Wunderlich et al., 2005; Back, 2007). The amount of 
XN in commercial beers is low: 0.2 mg/L or less (Wunderlich et al., 2005). However, 
addition of dark malts that contain several unidentified soluble substances with a 
molecule size range of 600,000-300,000 Da form complexes with  beer compounds and 
might protect XN during the boiling process and reduce its isomerization to IX, a 
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compound that is not as biologically beneficial as XN (Wunderlich et al., 2005; Back, 
2007). By utilizing the combination of dark malts and XN-enriched hop products, a beer 
with a XN content of 17.2 mg/L was developed (Wunderlich et al., 2005). XAN 
technology focuses on enriching XN content in beer produced under Reinheitsgebolt, the 
German purity law, which mandates hops are added during wort boil. This process 
exposes XN to heat, which isomerizes it to IX.  
One example of a beer style that may inherently contain more XN is the India 
Pale Ale (IPA). More specifically, American IPA is a style of beer containing American 
hop varieties and often utilizes dry hopping where hops are added after the wort has been 
cooled and while the beer ferments (Guinard, 1990). Dry hopping contributes to hop 
aroma but not bitterness as alpha acids need to be isomerized during wort boiling to form 
the bitter tasting iso-alpha acids (De Keukeleire, 2000). Information on bioactive 
compounds in American IPA beers is limited. One study analyzed prenylflavonoids in 
different beer styles and reported XN content of 0.16 mg/L in an India Pale Ale (Stevens 
et al., 1999b), this amount is expected to be higher in beers that are dry hopped.  
We hypothesized that 1) American IPAs will have higher amounts of XN, TP and 
antioxidant capacity compared to non IPA style beers and addition of dark malts and dry 
hopping increases the XN content, TP, and antioxidant activity  2) Beer matrix will have 
higher anti-proliferative and pro-apoptotic properties in vitro compare to isolated XN 
and/or IX. To test these hypotheses different brands of IPAs were analyzed for total 
phenolics (TP), antioxidant activity, and amounts of XN and IX. This research also 
addressed the effect of processing techniques (dry hopping and filtration) and ingredients 
(dark malts) on final XN and IX contents, and pro-apoptotic and anti-proliferative 
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properties of isolated compounds XN and/or IX, as well as whole beer matrixes in HCT 
116 (P53+/+) colon cancer cells. Results indicated that the amount of XN, TP, and 
antioxidant capacity of IPAs vary widely depending on the ingredients and processes 
used. However, certain IPAs contained much higher amounts of XN than were previously 
reported (Stevens et al., 1999b). Finally, beer matrix with a mixture of bioactive 
compounds along with XN and IX showed potent anti-proliferative and pro-apoptotic 
properties compared to isolated XN and/or IX at similar concentrations. 
 
2. Materials and Methods 
2.1 Materials  
Formic acid, Folin-Ciocalteu reagent, 6-hydroxy-2,5,7,8-tetramethylchroman 2-
carboxylic acid (Trolox), and 2,2’-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) 
(ABTS) radical were purchased from Sigma (St. Louis, MO). Na2CO3 was purchased 
from Mallinckrodt (Paris, KY) and Gallic acid was purchased from Acros Organics 
(North Hampton, NH). XN and IX standards were purchased from Enzo Life Sciences 
(Plymouth Meeting, PA) and chlorogenic acid was procured from Indofine 
(Hillsborough, NJ). For the cell culture assays, McCoy’s 5A modified medium, 
Dulbecco’s modified Eagle’s medium F-12, bovine serum albumin, and sodium 
bicarbonate were purchased from Sigma (St. Louis, MO). Fetal bovine serum, 
streptomycin/penicillin mix and 5% activated charcoal were obtained from Fisher 
Scientific (North Hampton, NH). Caspase-Glo 3/7 was purchased from Promega 
Corporation (Madison, WI). IPAS were donated by breweries in Fort Collins, CO. The 
non IPA was purchased at a liquor store in Fort Collins, CO. 
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2. 2. Beer Preparation  
A total of 10 different beers were analyzed in this study. The effect of addition of 
dark malts on XN content in final beer was determined by collecting beer samples made 
from original Odell IPA recipe and from altering the Odell IPA recipe to contain 8.7% 
more darker malts. The effect of DE filtration on final XN contents in American IPAs 
was analyzed by collecting samples before and after filtration for three beer types. 
Finally, two different versions of the Zenith IPA, one dry hopped and the other non-dry 
hopped were tested to determine the effect of dry hopping on the final XN content. 
Different types of IPAs used in this study and information on beer preparation of each of 
these IPAs is presented in Table 2.1.   
New Belgium Brewing Company’s Ranger IPA contained a grain bill that 
consisted of two-row Pale and Crystal 120 malt. Both T-90 pellets and CO2 extract were 
used for hop additions during the brew. The beer was dry hopped with Cascade hops. 
Chinook and Simcoe hops were also used. The Ranger had 70 IBUs (international 
bitterness units), 185 calories, and 6.5% ABV (alcohol by volume).  
The Odell IPA contained Pale, Munich, Crystal, and Cara malts. Columbus 
(Hopsteiner- 14.4% alpha acids), Chinuk (Hop Union 10.5% alpha acids), Perle (Hop 
Union 7.7% alpha acids 3.4% beta acids) Amerillo (Hop Union 8.2% alpha acids), and 
Centennial (Hopsteiner 8.0% alpha acids) were added during and right after the boil. All 
hops used were pelleted. After several days of fermentation, three types of pelleted hops 
were added to the fermentation vessel. Other attributes of this beer include 70 IBUs and 




Table 2.1. IPA samples and preparation method in September, 2010.  
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The Odell Dark IPA was a scaled down version (5 barrels) of the Odell IPA. The 
original grain bill was altered to contain 8.7% more dark malt. The grain bill was as 
follows: 55 lbs ESB (Extra Special British), 250 lbs Pale, 20 lbs Munich, 20 lbs 100-120 
Crystal, 15 lbs Cara, 11 lbs Carafa III, 5 lbs Amber. Three-hundred and fifty g Columbus 
(Hopsteiner- 14.4% alpha acids) hops were added at 90 minutes left in the boil, 350 g of 
Chinuk (Hop Union 10.5% alpha acids) hops were added at 45 minutes, 1000 g of Perle 
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(Hop Union 7.7% alpha acids 3.4% beta acids) hops were added at the end of the boil, 
1360 g of Amerillo (Hop Union 8.2% alpha acids) hops and 360 g of Centennial 
(Hopsteiner 8.0% alpha acids) hops were added before the knock out. All hops used were 
pelleted. After a several days of fermentation, 2.2 lbs each of three types of pelleted hops 
were added to the fermentation vessel. Other attributes of the Dark IPA include 70 IBUs 
and 7.7% ABV. For the first three beers, samples were taken from various stages of 
transfer before filtration (RGP, OOP, and ODP) and before final bottling (RGF, OOF, 
and ODF) to address the effect of DE filtration on XN content.  
Equinox Brewing Company’s Zenith IPA contained 7.75 lbs Pale malt, 1 lb 
Aromatic malt, 0.90 lb Munich malt, 0.4 lb Carapils Malt, 0.40 lb crystal/caramel 30L 
(Degrees Lovibond, indicating darker malts), and 0.4 lb Debittered black malt. A total of 
0.85 oz of Columbus pelleted hops were steeped in the wort during the boil, 1 oz. pelleted 
Golding hops were added at 15 minutes left in the boil, 1 oz. pelleted Amarillo hops were 
added at 10 minutes left in the boil, and 1 oz. Simcoe hops were added at 5 minutes left 
in the boil. For ZOR, 2 oz. of pelleted Centennial hops were added at the beginning of the 
whirlpool. For ZNR, 1 oz. pelleted Centennial hops were added at the beginning of the 
whirlpool, and 1 oz of whole leaf hops were added during fermentation. The beers were 
chilled and fermented with British ale yeast. Prior to bottling, the fining agent Biofine 
Clear was used in a ratio of 30 mL per 300 gallons of beer to remove undesired 
sedimentation. Beer specifications include: OG: 1.058, FG 1.012, ABV 6.0%, IBU 75. 
Four samples of each beer were taken at different time points of keg tapping.  
CooperSmith’s Punjabi Pale Ale (PPA) was created with Pale malts and light and 
medium Crystal malts for the grain bill. Centennial, Columbus, and Cascade pelleted 
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hops were used and added in the following amounts and times: 10 lbs in kettle, 2.5 lbs at 
90 minutes, 2.5 lbs at 30 minutes, 2.5 lbs at 5 minutes, 2.5 lbs at 1 minute, 3.5 lbs in 
whirlpool, and 3 pounds in aging tank. This beer contained 56 IBUs and 6.8% ABV and 
was brewed in 9 barrel batches. Four samples of the beer were taken at different time 
points of keg tapping. 
Paulaner Pils (PPI) was a German-style Pilsner (pils) beer and contained 
4.9% alcohol by volume (ABV). German Pilsners are typically made with Pilsner malts, 
German hop varieties, and German lager yeasts  (Pavsler et al., 2009). Compared to the 
other beers, it was the lightest in color and highest in carbonation. It was the only beer 
purchased at a liquor store and samples were collected randomly from four bottles from 
the same 6-pack packaging.  
2.3 Sample Preparation for Analytical Assays 
Beer samples collected at breweries were transported on ice to the lab. All 
samples were stored at -80C in 50 mL falcon tubes. The samples were thawed at 4C 
and centrifuged at 1600 rpm for 20 minutes, and the supernatant was collected for 
analysis. Though some studies used solid phase extraction to extract bioactive 
compounds from beers before determining the content of XN (Magalhaes et al., 2008), a 
recent study showed a reduction in the XN recovery after C18 solid phase extraction of 
dark beers (Wunderlich et al., 2009; Haseleu et al., 2010). Thus, in this study the 
supernatant after centrifugation of beer was directly used for antioxidant activity, total 
phenolic content and LC-MS analysis. Beer samples were filtered and evaporated under 




2.4. Identification of XN and IX Using LC/MS/MS 
A Waters Acquity UPLC system with a BEH C18 column (1.7 µM, 1.0 x 100 
mm) was used for chromatographic separation. Samples were eluted using a gradient 
mobile phase for 16 min at a flow rate of 140 µL/min. Solvent A was 5% acetonitrile, 5% 
water, 0.1% formic acid and solvent B was 95% acetonitrile, 5% water, 0.1% formic acid. 
Solvent A flow (100%) was maintained for 1 min followed by a gradient run from 100% 
A to 100% B over 10 minutes and maintained at 100% B for 2 min followed by 100% A 
for 3 min to re-equilibrate the column to original condition. The column and auto-sampler 
were maintained at 50°C and 5°C, respectively.   
Column eluent was infused into a Micromass Q-Tof fitted with an electrospray 
source. Data was collected in negative polarity MS/MS mode, scanning from 50-1000 
with a 0.5 second scan time and a 0.1 second interscan delay. Calibration was performed 
prior to sample analysis via infusion of sodium formate solution, with mass accuracy 
within 3 ppm. The capillary voltage was held at 2200V, the source temp at 130°C, and 
the desolvation temperature at 300°C with nitrogen desolvation gas flow rate of 300 L/hr. 
The quadrupole was held at collision energy of 18 electron volts for fragmentation. Both 
internal standard and target analytes were quantified using MS/MS fragmentation to 
improve specificity. Chlorogenic acid, an internal standard, isolated using mass 353.08, 
with product ion 191.06 eluting at 2.7 minutes served as the target for quantitation. Both 
IX and XN were quantified using the parent ion 353.14 and targeting the fragment ion 
233.08 at retention times 6.01 and 7.84 minutes, respectively. Each beer type was tested 
in quadruplicate with two technical replications for each sample, for a total of eight 
replications. All sample areas were standardized using chlorogenic acid peaks as the 
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spiking rate was tenfold above detectable amounts of chlorogenic acid found inherently 
in the beer samples. Because detectable amounts of XN and IX were found in the beer 
matrix in which the dose response curve was prepared, these native areas were subtracted 
from all seven points before the dose-response curve was calibrated. The XN and IX dose 
response curve (338, 675, 1250, 2500, 5000, 10000, and 20000 ng/mL) had R
2
 values of 
0.999 and 0.992, respectively.  
2.5 Total Phenolics Assay 
 
The Folin-Ciocalteau reagent (FCR) assay was used to measure the total phenolic 
content of beer samples (Reddivari et al., 2007). The FC reagent was a mixture of 
phosphomolybdate and phosphotungstate and when exposed to samples, inherent 
phenolic compounds donated their electrons to the phosphomolybdic/phosphotungstic 
acid complexes imparting color change. Gallic acid was used to set the standard curve 
(R
2
>0.99). Stored samples were diluted and tested in duplicate with four technical 
replications for each sample, for a total of eight replications. Samples were added to a 96 
micro-well plate (35 µl per sample). Then 150 µl of 0.2 M Folin-Ciocalteau reagent was 
added to each well. After being shaken and left to stand for 5 minutes, 115 µl 7.5% 
Na2CO3 was added to all wells. Plates were held at room temperature for 1 hour before 
being read by a spectrophotometer (Synergy 2, BioTek, Winooski, VT) at a wavelength 
of 765 nm. Values were expressed as milligrams Gallic acid equivalent (GAE) per liter of 
sample ± SE.  
2.6 Antioxidant Capacity Assay 
 
The ABTS Trolox Equivalent Antioxidant Capacity assay (TEAC) was used to 
measure total antioxidant activity of the beer samples (Reddivari et al., 2007). This assay 
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measures the loss of color to the ABTS blue-green chromophore (free radical) 
when an antioxidant is added. A mother solution of ABTS was prepared by 
mixing 8 mM ABTS solution and 3 mM of potassium persulfate, which reacted in 
the dark for 12 hours. Then a working solution was made fresh every time by 
adding 5 mL of the mother solution to 45 mL of phosphate buffer.  
Samples were diluted so that the absorbance reading was between 0.1-1.5. Diluted 
samples (10 µl) and ABTS working solution (290 µl )were mixed in a 96 micro-well 
plate and read in the spectrophotometer at 734 nm. Each beer type was tested in 
quadruplicate with four technical replications (16 replications in total). Results were 
expressed in milligrams TEAC per liter of sample ± SE. 
2.7 Cell Lines 
 
Human colon carcinoma cell line HCT-116 p53 +/+, gift from Dr. Bert 
Vogelstein, was maintained at 37ºC in 5% CO2 jacketed incubator in McCoy’s 5A 
modified medium supplemented with 2.0 g/L sodium bicarbonate, 0.11 g/L sodium 
pyruvate, 4.5 g/L glucose, 100 mL/L fetal bovine serum, and 10 mL/L antibiotic 
antimycotic solution.  
2.8 Cell Proliferation Assay 
 
Four beers were selected based on the content of XN or IX. OOP and ODP (with 
the highest XN content, ZNR (with the highest IX content), and PPI (with the lowest XN 
content) were used for in vitro assays. Centrifuged beer samples were filtered using a 0.2 
µm nylon filter membrane and evaporated to completion under nitrogen gas. Then 1 mL 
of media was added to dissolve beer compounds. Cells were plated at a density of 5.0 X 
10
4
 per well in a 12-well plate. After 24 hours, growth medium was replaced with 2.5% 
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serum stripped Dulbecco’s modified Eagle’s medium F-12 containing either four beer 
samples in three concentrations (5, 10, 15 µg/mL GAE), or XN/IX at highest beer 
concentration (12.69 ng/mL), (2 ng/mL), XN + IX (12.69 ng/mL + 1 ng/mL), and XN at 
a concentration that previously has shown anti-proliferative activity (3.5 µg/mL) 
(Hadjiolov et al., 2009) were added. Ethanol was used as the control, as isolated 
compounds were dissolved in 80% ethanol. After 24 h of incubation with the treatments, 
cell proliferation (cell number) was measured using a Cellometer Auto T4 counter 
(Nexcelom Bioscience, Lawrence, MA). Results were expressed as means ± SEs. 
2.9 Apoptosis  
 
Cells were plated at a density of 5.0 X 10
4
 per well in 12-well plates. After 24 h, 
growth media was replaced with Dulbecco’s modified Eagle’s medium F-12 media 
containing 2.5% charcoal stripped serum, and four beers were tested at three different 
concentrations (5, 10, 15 µg GAE /ml ). After 24 h, 15,000 cells for each treatment were 
transferred to a 96-well white luminescence plate. Media was added to each well to make 
a total 200 µl followed by 100 µl of Caspase-Glo 3/7. The cells were incubated for 30 
minutes in the dark and shaken thoroughly for one minute before the luminescence 
reading. Results were expressed as means ± SEs. 
2.10. Statistical Analysis      
 
Differences among means were calculated using Tukey’s Honest Significant 
Difference (HSD) test using SPSS Software. For all comparisons, P-values ≤ 0.05 were 
considered significant. ANOVA was performed using SPSS. Pearson correlation 




3. Results and Discussion  
Ten different beers were analyzed for XN, IX, total phenolic content, and 
antioxidant activity. Of the ten beers tested, eight contained detectible amounts of XN 
(Figure 3.1 and Figure 3.2). ODP and ODF contained the highest amounts of XN: 12.69 
and 12.62 mg/L, respectively. XN contents in the original IPA recipes were lower (p  ≤ 
0.05) than the dark IPA: OOP (11.18 mg/L) and OOF (9.94 mg/L). Much lower amounts 
of XN were found in the other four beer samples: RGP (0.67 mg/L), RGF (0.44 mg/L), 
ZOR (0.15 mg/L), and ZNR (0.26 mg/L). Many IPAs tested in this study showed higher 
levels of XN compared to the earlier reports of 0.16 mg/L XN (Stevens et al., 1999b), 
which supports our hypothesis.  
3.1 Effect of Addition of Roasted Malts, Filtration, and Dry Hopping on XN Content 
The grain bill of the Odell IPA original recipe (OOP and OOF) was altered to 
contain 8.7% more roasted malts to prepare ODP and ODF. Beers with additional dark 
malts (ODP and ODF) showed the highest amount of XN (12.69 and 12.62 mg/L, 
respectively). Substances (600,000-300,000 Da) in roasted malts might form complexes 
with XN to protect it from isomerization to IX during wort boiling (Wunderlich et al., 
2005; Back, 2007; Wunderlich et al., 2009).  
The amount of XN in pre-filtered and filtered beers was dependent on the types of 
IPA. Results indicate DE filtration removed 34.3% of the XN content in the Ranger beer 
and 11.10% in the Odell IPA. The addition of dark malts reduced the removal of XN 
upon filtration and only a 0.55% reduction in XN content in Odell Dark IPA was 
observed. The data support our hypothesis that the use of dark malts decreases the 





Figure 3.1. XN content of beer samples using UPLC/MS/MS. Ranger Pre-DE filtration 
(RGP*); Ranger Post-DE Filtration (RGF*); Odell IPA Pre-DE filtration (OOP*); Odell 
IPA Post-DE Filtration (OOF*); Odell Dark IPA Pre-DE filtration (ODP*); Odell Dark 
IPA Post-DE Filtration (ODF*); Zenith Original Recipe (ZOR); Zenith New Recipe 
(ZNR*); Punjabi Pale Ale (PPA*); and Paulaner Premium Pils (PPI). Data expressed as 
the mean of eight replications ± SE. Different letters on the bars represent significant 
differences at p ≤ 0.05  in XN content among the beer samples. *Indicates dry hopped 
beers. 
 
filtration (Wunderlich S., 2007). 
In addition to the use of dark malts, both the Odell Dark IPA and the Odell IPA 
are heavily dry hopped (6.6 lbs of dry hops were added to 5 barrels of beer, which is 
equal to 0.055 oz. for 0.3 L of beer). This ratio of dry hops to beer is likely the highest of 
all beers tested in this study (ZNR: 0.016 oz. and PPA: 0.014 oz. of dry hops per 0.3 L of 
beer). RGP and RGF were also dry hopped but the amounts and type of hops (T-90 
pellets and CO2 extract) were not known. The low amount of XN in RGP and RGF (0.67 
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Figure 3.2 UPLC-MS/MS chromatograms. Analysis of chlorogenic acid (rt. 2.7 min), IX 
(rt. 6.01 min), and XN (rt. 7.84 min). For further details on UPLC run and interpretation, 
see section 2.3. Call out boxes show the peak intensities at reduced scale.  
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3.2 Effect of Addition of Roasted Malts, Filtration, and Dry Hopping on IX Content 
CO2 extract for dry hopping. This is because CO2 hop extraction recovers less than 5% 
XN in the original hop cone (Biendl et al., 2004b).  
ZNR was prepared with 1 oz of dry hops while the ZOR contained the same 
amount of hops but all hops were added before the wort was cooled. This change in hop 
addition did result in a significant difference in XN content of ZNR (0.26 mg/L) and 
ZOR (0.15 mg/L). It is surprising that both Zenith beers did not contain more XN 
considering they were prepared with debittered black malt. These beers were both treated 
with Biofine Clear, a product that removes yeast and other haze forming particles based  
on colloidal silicon dioxide. Biofine Clear treatment might be associated with removing 
polyphenolic compounds, such as XN. Other explanations for varying amounts of XN in 
dry hopped beers analyzed in this study could include differences in the temperature and 
time of hop and beer contact during fermentation. 
3.2 Effect of Addition of Roasted Malts, Filtration, and Dry Hopping on IX Content.  
 
A variation in IX content was observed in the beers sampled (Figure 3.3). The IX 
content was lowest in RGF (0.30 mg/L) and highest in ZNR (1.82 mg/L). The use of 
roasted malts did increase the amount of IX observed as OOP contained 0.92 mg IX/L 
and ODP contained 1.08 mg IX/L. Filtration did not necessarily reduce the amount of IX 
in dark IPAs. In ODP the IX content actually increased from 1.08 to 1.27 mg/L. 
However, a slight decrease was seen in the other beers after filtration (RGP: 0.49; RGF: 
0.30; OOP: 0.92; OOF: 0.86). All differences in IX content before and after filtration of 
beers were not statistically different.  
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The amount of IX was expected to be higher in certain beers because of the small 
amount of XN detected. For example, PPA contained no detectable amounts of XN even  
 
 
Figure 3.3. IX content of beer samples using UPLC/MS/MS. Ranger Pre-DE filtration 
(RGP*); Ranger Post-DE Filtration (RGF*); Odell IPA Pre-DE filtration (OOP*); Odell 
IPA Post-DE Filtration (OOF*); Odell Dark IPA Pre-DE filtration (ODP*); Odell Dark 
IPA Post-DE Filtration (ODF*); Zenith Original Recipe (ZOR); Zenith New Recipe 
(ZNR*); Punjabi Pale Ale (PPA*); and Paulaner Premium Pils (PPI). Data expressed as 
the mean of eight replications ± SE. Different letters on the bars represent significant 
differences at p ≤ 0.05 in IX content among the beer samples. *Indicates dry hopped 
beers.  
 
though it was dry hopped with 3 lbs. of pelleted malts for a 9 barrel batch. This beer also 
contained low amounts of IX. Possible reasons for low amounts of these compounds in 
this beer include poor extraction from the pelleted hops or that perhaps the pelleted hops 
did not contain XN, although XN is not typically lost in the pelletizing process (Biendl et 
al., 2004b). For other beers, such as ZOR and ZNR, the low amount of XN could be the 
result of the isomerization of XN to IX as amounts were statistically higher than all other 
beers. Although the difference in IX content between ZOR and ZNR was not statistically 
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significant, a trend was observed that the amount of IX was lower in ZOR than in ZNR. 
The reverse was expected as all the hops in ZOR were exposed to heat and 1 oz. of hops 
in ZNR were not. Perhaps the hops added during dry hopping contained inherent amounts 
of IX due to isomerization, which could account for this finding.   
3.3 Variation in TP Content among Beers Sampled  
The TP content of all IPAs style was significantly higher than that of PPI, the 
German-style Pilsner: 190.47 mg/L GAE (Figure 3.4). This is likely due to IPAs 
containing more hops and a larger variation in malts than do Pilsners. The highest TP 
content in the IPAs was observed in ODP (504.35 mg/L GAE) and could be attributed to 
the fact that this beer contained the highest amount of dark mats, was not filtered, and 
was heavily dry hopped. ODF had a slight reduction in TP content (482.90 mg/L GAE), 
indicating DE filtration resulted in a reduction of total phenolics in beer. Upon filtration 
the Odell IPA contained a significantly lower total phenolic content: 480.74 mg/L GAE 
 
Figure 3.4. TP content analyzed by the Folin-Ciocalteau reagent assay. Ranger Pre-DE 
filtration (RGP*); Ranger Post-DE Filtration (RGF*); Odell IPA Pre-DE filtration 
(OOP*); Odell IPA Post-DE Filtration (OOF*); Odell Dark IPA Pre-DE filtration 
(ODP*); Odell Dark IPA Post-DE Filtration (ODF*); Zenith Original Recipe (ZOR); 
Zenith New Recipe (ZNR*); Punjabi Pale Ale (PPA*); and Paulaner Premium Pils (PPI). 
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Data expressed as the mean of eight replications ± SE. Different letters on the bars 
represent significant differences at p ≤ 0.05 in TP content among the beer samples. 
*Indicates dry hopped beers 
 
was reduced to 392.47 mg/L GAE. These results indicate that the addition of roasted 
malts could also minimize the removal of other phenolic compounds besides XN from 
the beer matrix upon DE filtration. TP content in RGF was slightly reduced compared to 
RGP, but this reduction was not statistically significant. ZOR contained less XN and IX 
compared to ZNR, but this did not correlate with total phenolic content (360.81 and 
413.22 mg GAE/L, respectively). Even though some of the IPAs did not contain 
increased levels of XN as was expected, these beers still showed significant TP content. 
This may be due to the presence of other hop derived compounds. For example, RGP and 
RGF were made with both CO2 hop extracts and pelleted hops. While the CO2 extract 
recovers less than 5% XN in the original hop cone (Biendl et al., 2004b), other hop 
derived compounds such as alpha and beta acids are captured and preserved  in this 
extract (Hopsteiner, 2010). Given that hop derived compounds besides XN are present in 
the CO2 hop extracts it is not surprising the Ranger beers had similar total phenolic 
content as that of ZOR, ZNR and PPA. 
3.4 Variation in ABTS Reducing Equivalent Capacity  
The highest antioxidant capacity value was observed for ODP: 1327.38 mg/L 
TEAC (Figure 3.5). The antioxidant capacity of PPI (836.45 mg/L TEAC) was not 
significantly different from PPA (1035.75 mg/L TEAC), ZNR (958.65 mg/L TEAC), and 
ZOR (1095.0 0mg/L). This indicates that malt and hop derived compounds inherent in 
Pilsner-style beers contributed to the antioxidant capacity, although this amount is 
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statistically lower than beers containing darker malts and greater amounts of hop 
products.   
Antioxidant capacity of RGP and RGF were 1323.98 and 1115.49 mg/L TEAC, 
respectively. These results indicate other compounds besides phenolic compounds 
contribute to antioxidant capacity in beer samples. This can be due to the fact that certain 
hop derived phenolic compounds, such as alpha acids, transform into trans-and cis-iso-
alpha acids isocohumulone, cis-isocohumulone, trans-isohumulone, cis-isohumulone, 
trans-isoadhumulone, cis-(Intelmann et al., 2009). These compounds are not accounted  
 
Figure 3.5 Antioxidant capacity analyzed by the ABTS Trolox Equivalent Antioxidant 
Capacity Assay. Ranger Pre-DE filtration (RGP*); Ranger Post-DE Filtration (RGF*); 
Odell IPA Pre-DE filtration (OOP*); Odell IPA Post-DE Filtration (OOF*); Odell Dark 
IPA Pre-DE filtration (ODP*); Odell Dark IPA Post-DE Filtration (ODF*); Zenith 
Original Recipe (ZOR); Zenith New Recipe (ZNR*); Punjabi Pale Ale (PPA*); and 
Paulaner Premium Pils (PPI). Data expressed as the mean of eight replications ± SE. 
Different letters on the bars represent significant differences at p ≤ 0.05 in antioxidant 




for in the total phenolics assay, but could play a role in antioxidant capacity. This could 
be the reason why RGP and RGF had a higher antioxidant capacity than total phenolic 
content compared to other beers.  
3.5 Cell Proliferation and Apoptosis  
 
XN is well known for its biological benefits and has been found to inhibit colon 
cancer cell proliferation at 10 mM concentrations (3.5 µg/mL) (Hadjiolov et al., 2009). 
However, no studies have focused on the synergistic effect of beer compounds in relation 
to colon cancer cell proliferation and cell death. This study tested four beer samples at 
three different concentrations on colon cancer lines HCT-116 p53 +/+ as well as pure XN 
 
Figure 3.6. Anti-proliferative effects of isolated vs. whole beer matrixes on HCT-116 p53 
+/+ human colon cancer cells. XN at highest beer concentration (12.69 ng/ml); IX at 
highest beer concentration (2 ng/ml); XN and IX at beer with highest XN concentration 
(12.69 ng/ml and 1 ng/ml, respectively); XN at (3.5 µg/ml); and beer samples: Odell IPA 
Pre-DE filtration (OOP); Odell Dark IPA Pre-DE filtration (ODP); Zenith New Recipe 
(ZNR); and Paulaner Premium Pils (PPI) at  GAE concentrations of 5, 10, and 15 µg/µL. 
Data expressed as the mean of three replications ± SE. Different letters on the bars 





Figure 3.7. Proapoptotic effects of isolated vs. whole beer matrixes on HCT-116 p53 +/+ 
human colon cancer cells.  XN at highest beer concentration (12.69 ng/ml); IX at highest 
beer concentration (2 ng/ml); XN and IX at beer with highest XN concentration (12.69 
ng/ml and 1 ng/ml, respectively); XN at (3.5 µg/ml); and beer samples: Odell IPA Pre-
DE filtration (OOP); Odell Dark IPA Pre-DE filtration (ODP); Zenith New Recipe 
(ZNR); and Paulaner Premium Pils (PPI) at  GAE concentrations of 5, 10, and 15 µg/µL. 
Data expressed as the mean of three replications ± SE. Different letters on the bars 
represent significant differences at p ≤ 0.05 in cell apoptosis among the beer samples. 
 
and/or IX. Results indicated that IPAs differed in their suppression of cancer cell 
proliferation (Figure 3.6) and elevation of apoptosis (Figure 3.7). 
IPAs with higher amounts of XN contained greater anti-proliferative and pro-
apoptotic properties and the effect was dose dependent. ODP and OOP were more potent 
in suppressing cell proliferation and elevating apoptosis. The highest amounts of XN in 
these beer matrixes are only 12.69 and 11.18 ng/mL, respectively, and both suppressed (p 
≤ 0.05) cell proliferation and elevated apoptosis compared to XN and/or IX at the similar 
concentrations.  These results indicate that XN in combination with other inherent beer 
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compounds is approximately 200 times more potent than isolated XN in reducing cell 
cancer growth. The observed effect of beer on colon cancer cells can be attributed to 
XN’s ability to increase activation of Caspase 3/7 enzyme, inhibit DNA synthesis, and 
induce cell cycle arrest in S-phase (Miranda et al., 2000; Hadjiolov et al., 2009). 
 
3.6 Correlation Coefficients among Different Parameters 
Significant positive correlations were observed between XN and other parameters 
such as TP, antioxidant capacity, and apoptosis (Table 3.1). Significant negative 
correlations were observed between XN and cell proliferation. However, no correlation 
was seen between IX and all other parameters analyzed. 
Table 3.1 Correlation coefficients and p-values between antioxidant activity (ABTS), 
total phenolics (TP), xanthohumol (XN), isoxanthohumol (IX), colon cancer cell 
proliferation (P), and Apoptosis (A) 
 
  
      
TP 
 
XN IX P A 
ABTS  0.852* 0.857* 0.008 -0.796* 0.876* 
  (0.0004) (0.0004) (0.9802) (0.0019) (0.0002) 
TP   0.878* 0.276 -0.901* 0.953* 
   (0.0002) (0.3851) (0.0001) (0.0001) 
XN    0.172 -0.785* 0.970* 







       -0.207    0.033 
     (0.5190) (0.9180) 
P      -0.863* 
      (0.0003) 




Samples of IPAs from different breweries and one German Pilsner were analyzed 
for total phenolic, antioxidant capacity, XN, and IX content to determine the effects of 
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filtration, addition of dark malts, and dry hopping. By adding dark, roasted malts into an 
already intensely dry hopped beer, a XN content of 12.62 mg/L was achieved after DE 
filtration. This research confirmed that certain IPAs on the market, especially those that 
are intensely dry hopped (0.055 oz. of hops per .3 L of beer), contained an increased 
amount of XN compared to the German Pilsner and beers with a XN concentration of 0.2 
mg/L. Beer made with increased amounts of dark malts contained significantly more XN, 
and pre-filtered beer contained more XN than filtered beer. The decrease in XN content 
due to filtration was significantly reduced in beer that contained increased dark malts. 
The recipe that contained dry hops had significantly more XN than the recipe without dry 
hops. Finally, cell culture assays confirmed beer mixtures with high amounts of XN 
suppressed cell proliferation and elevated apoptosis better than isolated components. 
It is possible that elevated amounts of XN in combination with other inherent beer 
compounds could possibly provide beneficial effects, such as increasing anti-oxidant 
activity, anti-proliferative and pro-apoptotic properties. While this study showed the 
combination of increasing roasted malts and dry hopping a beer during fermentation 
produced a product with an elevated XN content (without the use of XN-enriched hop 
products), additional information may enhance the implementation of this synergistic 
effect. While dark malts were added to produce ODP/ODF, the exact type of malts used 
could have been optimized in terms of potential to protect XN. Malts possessing the same 
color can be produced from different methods, which vary in the development of roasted 
substances, compared to Maillard reaction compounds. As reported by Wunderlich and 
Back (2007), protection of XN does not necessarily increase as the color of the malt 
intensifies. Furthermore, complete information on hop ingredients and the details of the 
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brewing process for beers analyzed in this study would provide greater insight as to how 
to optimize XN content in IPAs. Perhaps the process of dry hopping beers could be used 
to increase the sensory characteristics and prenylated flavonoid content of specific beer 
styles, such as low-alcohol beers. There are already non-alcoholic beverages tapping into 
the niche market of XN-enriched products; Beverages Xan Wellness and Xan Tea 
produced by TA XAN Plc are examples of products with elevated XN content for the 
purpose of enhancing health, but they are not widely available. The unification of 
consumers’ awareness of and desire for functional foods and XNs known biological 
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Figure A-1 Outline of beer production  
 























Figure A-3 Chromatogram for Ranger Filtered (RGF)  
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Figure A-4 Chromatogram for Odell IPA Prefiltered (OOP)  
 
Figure A-5 Chromatogram for Odell IPA Filtered (OOF)  
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Figure A-6 Chromatogram for Odell Dark IPA Prefiltered (ODP)  
 

























Figure A-8 Chromatogram for Zenith Original Recipe (ZOR)  
 
Figure A-9 Chromatogram for Zenith New Recipe (ZNR)  
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Figure A-10 Chromatogram for Punjabi Pale Ale (PPA)  
 
 
Figure A-11 Chromatogram for Paulaner Pilsner (PPI)  
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